Publications

2021

  1. Cooper I., Schnaider-Beeri M., Fridkin M. & Shechter Y. (2021) Pharmaceutics. 14, 1, 71.  Abstract
  2. Cooper I., Ravid O., Rand D. et_al. (2021) Pharmaceutics. 13, 10, 1557.  Abstract
  3. Eger M., Liron T., Hiram-Bab S. et_al. (2021) Frontiers in Pharmacology. 12, 638128.  Abstract

2019

  1. Cooper I., Atrakchi D., Walker M. D., Horovitz A., Fridkin M. & Shechter Y. (2019) Toxicology and Applied Pharmacology. 384, 114782.  Abstract
  2. Croci S., Bonacini M., Muratore F. et_al. (2019) Journal of Autoimmunity. 98, p. 113-121  Abstract
  3. Neuman H., Mor H., Bashi T. et_al. (2019) mSystems. 4, 1, ARTN e0016.  Abstract

2018

  1. Blank M., Bashi T., Lachnish J. et_al. (2018) PLoS ONE. 13, 8, 0200615.  Abstract
  2. Shemer A., Kivity S., Shovman O. et_al. (2018) Clinical and Experimental Immunology. 193, 2, p. 160-166  Abstract

2017

  1. Ben-Amram H., Bashi T., Werbner N., Neuman H., Fridkin M., Blank M., Shoenfeld Y. & Koren O. (2017) Frontiers in Microbiology. 8, 1222.  Abstract

2016

  1. Cooper I., Fridkin M. & Shechter Y. (2016) PLoS ONE. 11, 7, e0158352.  Abstract
  2. Bashi T., Shovman O., Fridkin M., Volkov A., Barshack I., Blank M. & Shoenfeld Y. (2016) Clinical and Experimental Immunology. 184, 1, p. 19-28  Abstract

2015

  1. Cooper I., Last D., Guez D. et_al. (2015) Journal of Cerebral Blood Flow and Metabolism. 35, 6, p. 967-976  Abstract
  2. Bashi T., Blank M., Shor D. B., Fridkin M., Versini M., Gendelman O., Volkov A., Barshak I. & Shoenfeld Y. (2015) Journal of Autoimmunity. 59, p. 1-7  Abstract
  3. Shor D. B., Bashi T., Lachnish J., Fridkin M., Bizzaro G., Barshak I., Blank M. & Shoenfeld Y. (2015) Journal of Autoimmunity. 56, p. 111-117  Abstract

2013

  1. Marcus Y., Shefer G., Sasson K. et_al. (2013) Diabetes. 62, 4, p. 1121-1130  Abstract

2012

  1. Cooper I., Sasson K., Teichberg V. I., Schnaider-Beeri M., Fridkin M. & Shechter Y. (2012) Journal of Biological Chemistry. 287, 53, p. 44676-44683  Abstract
  2. Shechter Y., Sasson K., Lev Goldman G. V., Rubinraut S., Rubinstein M. & Fridkin M. (2012) Bioconjugate Chemistry. 23, 8, p. 1577-1586  Abstract
  3. Zheng H., Fridkin M. & Youdim M. B. H. (2012) Current Drug Targets. 13, 8, p. 1089-1106  Abstract
  4. From Antioxidant Chelators to Site-Activated Multi-Target Chelators Targeting Hypoxia Inducing Factor, Beta-Amyloid, Acetylcholinesterase and Monoamine Oxidase A\B
    Zheng H., Fridkin M. & Youdim M. B. H. (2012) Mini-Reviews in Medicinal Chemistry. 12, 5, p. 364-370  Abstract
  5. Zheng H., Amit T., Bar-Am O., Fridkin M., Youdim M. B. H. & Mandel S. A. (2012) Journal Of Alzheimers Disease. 30, 1, p. 1-16  Abstract

2011

  1. Blank M., Baraam L., Eisenstein M., Fridkin M., Dardik R., Heldman Y., Katchalski-Katzir E. & Shoenfeld Y. (2011) Journal of Autoimmunity. 37, 1, p. 8-17  Abstract

2010

  1. Zheng H., Fridkin M. & Youdim M. B. H. (2010) Neurochemical Research. 35, 12, p. 2117-2123  Abstract
  2. Zheng H., Youdim M. B. H. & Fridkin M. (2010) ACS Chemical Neuroscience. 1, 11, p. 737-746  Abstract
  3. Zheng H., Youdim M. B. H. & Fridkin M. (2010) ACS Chemical Biology. 5, 6, p. 603-610  Abstract
  4. Shechter Y., Heldman E., Sasson K., Bachar T., Popov M. & Fridkin M. (2010) ACS Chemical Neuroscience. 1, 5, p. 399-406  Abstract
  5. Rubin N., Perugia E., Wolf S. G., Klein E., Fridkin M. & Addadi L. (2010) Journal of the American Chemical Society. 132, 12, p. 4242-4248  Abstract
  6. Sasson K., Marcus Y., Lev Goldman G. V., Rubinraut S., Fridkin M. & Shechter Y. (2010) Journal of Controlled Release. 142, 2, p. 214-220  Abstract
  7. Rahimipour S., Gescheidt G., Bilkis I., Fridkin M. & Weiner L. (2010) Applied Magnetic Resonance. 37, 4-Jan, p. 629-648  Abstract
  8. Gal S., Zheng H., Fridkin M. & Youdim M. B. H. (2010) Neurotoxicity Research. 17, 1, p. 15-27  Abstract

2009

  1. Zheng H., Youdim M. B. H. & Fridkin M. (2009) Journal of Medicinal Chemistry. 52, 14, p. 4095-4098  Abstract
  2. Kasher R., Bajayo A., Gabet Y., Nevo N., Fridkin M., Katchalski-Katzir E., Kohen F. & Bab I. (2009) Peptides. 30, 6, p. 1181-1186  Abstract
  3. Perugia E., Monticelli E., Rubinraut S., Kapitkovsky A. & Fridkin M. (2009) Peptides For Youth. 611, p. 69-70  Abstract

2008

  1. Trebicz-Geffen M., Robinson D., Evron Z. et_al. (2008) International Journal of Experimental Pathology. 89, 5, p. 321-331  Abstract
  2. Shechter Y., Mironchik M., Rubinraut S., Tsubery H., Sasson K., Marcus Y. & Fridkin M. (2008) European Journal of Pharmaceutics and Biopharmaceutics. 70, 1, p. 19-28  Abstract
  3. Lev Goldman G. V., Mester B., Ben-Aroya N. et_al. (2008) Bioorganic & Medicinal Chemistry. 16, 14, p. 6789-6798  Abstract
  4. Marcus Y., Sasson K., Fridkin M. & Shechter Y. (2008) Journal of Medicinal Chemistry. 51, 14, p. 4300-4305  Abstract
  5. Rubin N., Perugia E., Goldschmidt M., Fridkin M. & Addadi L. (2008) Journal of the American Chemical Society. 130, 14, p. 4602-+  Abstract
  6. Dangoor D., Biondi B., Gobbo M., Vachutinski Y., Fridkin M., Gozes I. & Rocchi R. (2008) Journal of Peptide Science. 14, 3, p. 321-328  Abstract
  7. Pneumococcal capsular polysaccharide is immunogenic when present on the surface of macrophages and dendritic cells: TLR4 signaling induced by a conjugate vaccine or by lipopolysaccharide is conducive
    Cohen N., Stolarsky-Bennun M., Amir-Kroll H. et_al. (2008) Journal of Immunology. 180, 4, p. 2409-2418  Abstract
  8. Nesher M., Vachutinsky Y., Fridkin G., Schwarz Y., Sasson K., Fridkin M., Shechter Y. & Lichtstein D. (2008) Bioconjugate Chemistry. 19, 1, p. 342-348  Abstract
  9. Blat D., Weiner L., Youdim M. B. H. & Fridkin M. (2008) Journal of Medicinal Chemistry. 51, 1, p. 126-134  Abstract

2007

  1. Tirosh B., Daniel-Carmi V., Carmon L. et_al. (2007) British Journal of Cancer. 97, 12, p. 1655-1663  Abstract
  2. Zhu W., Xie W., Pan T., Xu P., Fridkin M., Zheng H., Jankovic J., Youdim M. B. H. & Le W. (2007) FASEB Journal. 21, 14, p. 3835-3844  Abstract
  3. Avramovich-Tirosh Y., Rezrlichenko D., Amit T., Zheng H., Fridkin M., Weinreb O., Mandel S. & Youdim M. B. H. (2007) Current Alzheimer Research. 4, 4, p. 403-411  Abstract
  4. Dangoor D., Rubinraut S., Fridkin M. & Gozes I. (2007) Peptides. 28, 9, p. 1622-1630  Abstract
  5. Blank M., Anafi L., Zandman-Goddard G. et_al. (2007) International Immunology. 19, 7, p. 857-865  Abstract
  6. Shechter Y., Mironchik M., Saul A. et_al. (2007) International Journal of Peptide Research and Therapeutics. 13, 2-Jan, p. 105-117  Abstract
  7. Van der Schyf d. S. C. J., Mandel S., Geldenhuys W. J. et_al. (2007) Current Alzheimer Research. 4, 5, p. 522-536  Abstract
  8. Avramovich-Tirosh Y., Amit T., Bar-Am O., Zheng H., Fridkin M. & Youdim M. B. H. (2007) Journal of Neurochemistry. 100, 2, p. 490-502  Abstract

2006

  1. Dangoor D., Rubinraut S., Fridkin M. & Gozes I. (2006) Regulatory Peptides. 137, 2-Jan, p. 42-49  Abstract
  2. Burov S. V., Yablokova T. V., Dorosh M. Y., Shkarubskaya Z. P., Blank M., Epstein N. & Fridkin M. (2006) Russian Journal of Bioorganic Chemistry. 32, 5, p. 413-419  Abstract
  3. Lev Goldman G. V., Mester B., Ben-Aroya N., Koch Y., Weiner L. & Fridkin M. (2006) Bioconjugate Chemistry. 17, 4, p. 1008-1016  Abstract
  4. Shechter Y., Mironchik M., Amir S., Sela B., Tsubery H., Zheng H. & Fridkin M. (2006) International Journal of Peptide Research and Therapeutics. 12, 2, p. 121-129  Abstract
  5. Husebye E., Bratland E., Bredholt G., Fridkin M., Dayan M. & Mozes E. (2006) Endocrinology. 147, 5, p. 2411-2416  Abstract
  6. Fridkin G., Rahimipour S., Ben-Aroya N. et_al. (2006) Journal of Peptide Science. 12, 2, p. 106-115  Abstract
  7. M30, a novel multifunctional neuroprotective drug with potent iron chelating and brain selective monoamine oxidase-ab inhibitory activity for Parkinson's disease
    Gal S., Fridkin M., Amit T., Zheng H. & Youdim M. B. H. (2006) Journal Of Neural Transmission-Supplement. 70, p. 447-456  Abstract
  8. Novel neuroprotective neurotrophic NAP analogs targeting metal toxicity and oxidative stress: potential candidates for the control of neurodegenerative diseases
    Zheng H., Blat D. & Fridkin M. (2006) Journal Of Neural Transmission-Supplement. 71, p. 163-172  Abstract
  9. Scolnik Y., Portnaya I., Cogan U., Tal S., Haimovitz R., Fridkin M., Elitzur A., Deamer D. & Shinitzky M. (2006) Physical Chemistry Chemical Physics. 8, 3, p. 333-339  Abstract
  10. Zheng H., Blat D., Youdim M. B. H., Weiner L. M., Dangoor D., Gozes I. & Fridkin M. (2006) Understanding Biology Using Peptides. p. 443-444  Abstract

2005

  1. Dangoor D., Giladi E., Fridkin M. & Gozes I. (2005) Peptides. 26, 12, p. 2579-2584  Abstract
  2. Zheng H., Youdim M., Weiner L. & Fridkin M. (2005) Biochemical Pharmacology. 70, 11, p. 1642-1652  Abstract
  3. Zheng H., Youdim M., Weiner L. & Fridkin M. (2005) Chemical Biology and Drug Design. 66, 4, p. 190-203  Abstract
  4. Zheng H., Gal S., Weiner L., Bar-Am O., Warshawsky A., Fridkin M. & Youdim M. (2005) Journal of Neurochemistry. 95, 1, p. 68-78  Abstract
  5. Gal S., Zheng H., Fridkin M. & Youdim M. (2005) Journal of Neurochemistry. 95, 1, p. 79-88  Abstract
  6. Shechter Y., Goldwaser I., Mironchik M., Tsubery H. & Fridkin M. (2005) Pure and Applied Chemistry. 77, 9, p. 1617-1628  Abstract
  7. Shacham S., Cheifetz M., Fridkin M., Pawson A., Millar R. & Naor Z. (2005) Journal of Biological Chemistry. 280, 32, p. 28981-28988  Abstract
  8. Tsubery H., Yaakov H., Cohen S., Giterman T., Matityahou A., Fridkin M. & Ofek I. (2005) Antimicrobial Agents and Chemotherapy. 49, 8, p. 3122-3128  Abstract
  9. Shechter Y., Mironchik M., Rubinraut S., Saul A., Tsubery H. & Fridkin M. (2005) Bioconjugate Chemistry. 16, 4, p. 913-920  Abstract
  10. Shechter Y., Tsubery H., Mironchik M., Rubinstein M. & Fridkin M. (2005) FEBS Letters. 579, 11, p. 2439-2444  Abstract
  11. Rahimipour S., Litichever-Coslovsky N., Alaluf M., Freeman D., Ehrenberg B., Weiner L., Mazur Y., Fridkin M. & Koch Y. (2005) Photochemistry and Photobiology. 81, 2, p. 250-258  Abstract
  12. Slutzky L., Blank M., Goddard G., Fridkin M. & Shoenfeld Y. (2005) Arthritis Research & Therapy. 7, p. S8-S8  Abstract
  13. Zheng H., Weiner L., Bar-Am O., Epsztejn S., Cabantchik Z., Warshawsky A., Youdim N. & Fridkin M. (2005) Bioorganic & Medicinal Chemistry. 13, 3, p. 773-783  Abstract
  14. Youdim M., Fridkin M. & Zheng H. (2005) Mechanisms of Ageing and Development. 126, 2, p. 317-326  Abstract
  15. Prolonging the actions of protein and peptide drugs by a novel approach of reversible pegylation
    Shechter Y., Mironchik M., Rubinraut S., Saul A., Tsubery H. & Fridkin M. (2005) Peptides 2004, Proceedings: Bridges Between Disciplines. p. 48-51  Abstract
  16. Di-Segni S., Giordano C., Rahimipour S., Ben-Aroya N., Koch Y. & Fridkin M. (2005) Journal of Peptide Science. 11, 1, p. 45-52  Abstract
  17. Fridkin M., Tsubery H., Tzehoval E., Vonsover A., Biondi L., Filira F. & Rocchi R. (2005) Journal of Peptide Science. 11, 1, p. 37-44  Abstract

2004

  1. Barda Y., Cohen N., Lev V., Ben-Aroya N., Koch Y., Mishani E., Fridkin M. & Gilon C. (2004) Nuclear Medicine and Biology. 31, 7, p. 921-933  Abstract
  2. Youdim M., Fridkin M. & Zheng H. (2004) Journal of Neural Transmission. 111, 11-Oct, p. 1455-1471  Abstract
  3. Tsubery H., Mironchik M., Fridkin M. & Shechter Y. (2004) Journal of Biological Chemistry. 279, 37, p. 38118-38124  Abstract
  4. Peleg-Shulman T., Tsubery H., Mironchik M., Fridkin M., Schreiber G. & Shechter Y. (2004) Journal of Medicinal Chemistry. 47, 20, p. 4897-4904  Abstract
  5. Pierangeli S., Blank M., Liu X., Espinola R., Fridkin M., Ostertag M., Roye-Green K., Harris E. & Shoenfeld Y. (2004) Journal of Autoimmunity. 22, 3, p. 217-225  Abstract
  6. Kasher R., Gayer B., Kulik T., Somjen D., Venkatesh N., Fridkin M., Katchalski-Katzir E. & Kohen F. (2004) Biopolymers. 76, 5, p. 404-420  Abstract
  7. Peptides as a new family of compounds with estrogen-like activity
    Kasher R., Gayer B., Kulik T., Venkatesh N., Somjen D., Fridkin M., Katchalski-Katzir E. & Kohen F. (2004) Peptide Revolution: Genomics, Proteomics & Therapeutics. p. 512-514  Abstract

2003

  1. Katz M., Tsubery H., Kolusheva S., Shames A., Fridkin M. & Jelinek R. (2003) Biochemical Journal. 375, p. 405-413  Abstract
  2. Rahimipour S., Ben-Aroya N., Ziv K., Chen A., Fridkin M. & Koch Y. (2003) Journal of Medicinal Chemistry. 46, 19, p. 3965-3974  Abstract
  3. Shechter Y., Tsubery H. & Fridkin M. (2003) Biochemical and Biophysical Research Communications. 307, 2, p. 315-321  Abstract
  4. Shechter Y., Tsubery H. & Fridkin M. (2003) Biochemical and Biophysical Research Communications. 305, 2, p. 386-391  Abstract
  5. Shechter Y., Goldwaser I., Mironchik M., Fridkin M. & Gefel D. (2003) Coordination Chemistry Reviews. 237, 2-Jan, p. 3-11  Abstract
  6. Trebicz-Geffen M., Nevo Z., Evron Z., Posternak N., Glaser T., Fridkin M., Kollander Y. & Robinson D. (2003) Experimental and Molecular Pathology. 74, 1, p. 40-48  Abstract
  7. Rahimipour S., Palivan C., Barbosa F., Bilkis I., Koch Y., Weiner L., Fridkin M., Mazur Y. & Gescheidt G. (2003) Journal of the American Chemical Society. 125, 5, p. 1376-1384  Abstract
  8. Katchalski-Katzir E., Kasher R., Balass M., Scherf T., Harel M., Fridkin M., Sussman J. & Fuchs S. (2003) Biophysical Chemistry. 100, 3-Jan, p. 293-305  Abstract
  9. Gozes I., Divinsky I., Pilzer I., Fridkin M., Brenneman D. & Spier A. (2003) Journal of Molecular Neuroscience. 20, 3, p. 315-322  Abstract
  10. Fuchs S., Kasher R., Balass M., Scherf T., Harel M., Fridkin M., Sussman J. L. & Katchalski-Katzir E. (2003) Myasthenia Gravis And Related Disorders: Biomchemical Basis For Disease Of The Neuromuscular Junction. 998, p. 93-100  Abstract

2002

  1. Tsubery H., Ofek I., Cohen S., Eisenstein M. & Fridkin M. (2002) Molecular Pharmacology. 62, 5, p. 1036-1042  Abstract
  2. Gal R., Granoth R., Dreznik Z., Fridkin M. & Gozes I. (2002) Regulatory Peptides. 109, 3-Jan, p. 127-133  Abstract
  3. Steingart R., Heldenberg E., Pinhasov A., Brenneman D., Fridkin M. & Gozes I. (2002) Life Sciences. 71, 21, p. 2543-2552  Abstract
  4. Wollman Y., Blumberg S., Spungin A., Brenneman D., Fridkin M., Wollman J., Iaina A. & Gozes I. (2002) Regulatory Peptides. 108, 3-Feb, p. 175-177  Abstract
  5. Shechter Y., Tsubery H. & Fridkin M. (2002) Journal of Medicinal Chemistry. 45, 19, p. 4264-4270  Abstract
  6. Leker R., Teichner A., Grigoriadis N., Ovadia H., Brenneman D., Fridkin M., Giladi E., Romano J. & Gozes I. (2002) Stroke. 33, 4, p. 1085-1092  Abstract
  7. Blank M., Krause I., Fridkin M., Keller N., Kopolovic J., Goldberg I., Tobar A. & Shoenfeld Y. (2002) Journal of Clinical Investigation. 109, 6, p. 797-804  Abstract
  8. Urieli-Shoval S., Shubinsky G., Linke R., Fridkin M., Tabi I. & Matzner Y. (2002) Blood. 99, 4, p. 1224-1229  Abstract
  9. Moody T., Jensen R., Fridkin M. & Gozes I. (2002) Journal of Molecular Neuroscience. 18, 2-Jan, p. 29-35  Abstract
  10. Pelled D., Raveh T., Riebeling C., Fridkin M., Berissi H., Futerman A. H. & Kimchi A. (2002) Journal of Biological Chemistry. 277, 3, p. 1957-1961  Abstract

2001

  1. Sharma A., Walters J., Gozes Y., Fridkin M., Brenneman D., Gozes I. & Moody T. (2001) Journal of Molecular Neuroscience. 17, 3, p. 331-339  Abstract
  2. SH2 domain-containing inositol polyphosphate 5 '-phosphatase is the main mediator of the inhibitory action of the mast cell function-associated antigen
    Xu R., Abramson J., Fridkin M. & Pecht I. (2001) Journal of Immunology. 167, 11, p. 6394-6402  Abstract
  3. Tsubery H., Ofek I., Cohen S. & Fridkin M. (2001) Peptides. 22, 10, p. 1675-1681  Abstract
  4. Gelber E., Granoth R., Fridkin M., Dreznik Z., Brenneman D., Moody T. & Gozes I. (2001) Cancer. 92, 8, p. 2172-2180  Abstract
  5. Rahimipour S., Ben-Aroya N., Fridkin M. & Koch Y. (2001) Journal of Medicinal Chemistry. 44, 22, p. 3645-3652  Abstract
  6. Harel M., Kasher R., Nicolas A. et_al. (2001) Neuron. 32, 2, p. 265-275  Abstract
  7. Rahimipour S., Palivan C., Freeman D., Barbosa F., Fridkin M., Weiner L., Mazur Y. & Gescheidt G. (2001) Photochemistry and Photobiology. 74, 2, p. 149-156  Abstract
  8. Rahimipour S., Bilkis I., Peron V., Gescheidt G., Barbosa F., Mazur Y., Koch Y., Weiner L. & Fridkin M. (2001) Photochemistry and Photobiology. 74, 2, p. 226-236  Abstract
  9. Moody T., Leyton J., Chan D., Brenneman D., Fridkin M., Gelber E. & Gozes I. (2001) Breast Cancer Research and Treatment. 68, 1, p. 55-64  Abstract
  10. Shechter Y., Goldwaser I., Lavon I., Gershonov E., Mester B., Mironchik M., Patt L. & Fridkin M. (2001) Drugs of the Future. 26, 7, p. 669-676  Abstract
  11. Ashur-Fabian O., Giladi E., Furman S., Steingart R., Wollman Y., Fridkin M., Brenneman D. & Gozes I. (2001) Neuroscience Letters. 307, 3, p. 167-170  Abstract
  12. Scherf T., Kasher R., Balass M., Fridkin M., Fuchs S. & Katchalski-Katzir E. (2001) Proceedings of the National Academy of Sciences of the United States of America. 98, 12, p. 6629-6634  Abstract
  13. Tisch-Idelson D., Fridkin M., Wientjes F. & Aviram I. (2001) Biochemical Pharmacology. 61, 9, p. 1063-1071  Abstract
  14. Kasher R., Balass M., Scherf T., Fridkin M., Fuchs S. & Katchalski-Katzir E. (2001) Chemistry & Biology. 8, 2, p. 147-155  Abstract
  15. Shechter Y., Preciado-Patt L., Schreiber G. & Fridkin M. (2001) Proceedings of the National Academy of Sciences of the United States of America. 98, 3, p. 1212-1217  Abstract

2000

  1. Sigalov E., Fridkin M., Brenneman D. & Gozes I. (2000) Journal of Molecular Neuroscience. 15, 3, p. 147-154  Abstract
  2. Steingart R., Solomon B., Brenneman D., Fridkin M. & Gozes I. (2000) Journal of Molecular Neuroscience. 15, 3, p. 137-145  Abstract
  3. Tirosh B., Fridkin M., Tzehoval E., Vadai E., Lemonnier F. & Eisenbach L. (2000) Journal of Immunotherapy. 23, 6, p. 622-630  Abstract
  4. A peptide based on the CDR1 of a pathogenic anti-DNA antibody is more efficient than its analogs in inhibiting autoreactive T cells
    Eilat E., Fridkin M. & Mozes E. (2000) Immunobiology. 202, 4, p. 383-393  Abstract
  5. Brosh N., Zinger H., Fridkin M. & Mozes E. (2000) Cellular Immunology. 205, 1, p. 52-61  Abstract
  6. Organic vanadium chelators potentiate vanadium-evoked glucose metabolism in vitro and in vivo: Establishing criteria for optimal chelators
    Goldwaser I., Qian S., Gershonov E., Fridkin M. & Shechter Y. (2000) Molecular Pharmacology. 58, 4, p. 738-746  Abstract
  7. Tsubery H., Ofek I., Cohen S. & Fridkin M. (2000) Biochemistry. 39, 39, p. 11837-11844  Abstract
  8. Tsubery H., Ofek I., Cohen S. & Fridkin M. (2000) Journal of Medicinal Chemistry. 43, 16, p. 3085-3092  Abstract
  9. Vanadate restores glucose 6-phosphate in diabetic rats: a mechanism to enhance glucose metabolism
    Sun Q., Sekar N., Goldwaser I., Gershonov E., Fridkin M. & Shechter Y. (2000) American Journal Of Physiology-Endocrinology And Metabolism. 279, 2, p. E403-E410  Abstract
  10. Yahalom D., Rahimipour S., Koch Y., Ben-Aroya N. & Fridkin M. (2000) Journal of Medicinal Chemistry. 43, 15, p. 2831-2836  Abstract
  11. Yahalom D., Rahimipour S., Koch Y., Ben-Aroya N. & Fridkin M. (2000) Journal of Medicinal Chemistry. 43, 15, p. 2824-2830  Abstract
  12. Gershonov E., Goldwaser I., Fridkin M. & Shechter Y. (2000) Journal of Medicinal Chemistry. 43, 13, p. 2530-2537  Abstract
  13. Granoth R., Fridkin M. & Gozes I. (2000) FEBS Letters. 475, 2, p. 78-83  Abstract
  14. Granoth R., Fridkin M., Rubinraut S. & Gozes I. (2000) FEBS Letters. 475, 2, p. 71-77  Abstract
  15. Dayan M., Segal R., Sthoeger Z., Waisman A., Brosh N., Elkayam O., Eilat E., Fridkin M. & Mozes E. (2000) Journal of Clinical Immunology. 20, 3, p. 187-194  Abstract
  16. Goldwaser I., Gefel D., Gershonov E., Fridkin M. & Shechter Y. (2000) Journal of Inorganic Biochemistry. 80, 2-Jan, p. 21-25  Abstract
  17. Hexapeptide and cyclic pentapeptide endothelin antagonists directly activate pituitary gonadotropin-releasing hormone receptors
    Yahalom D., Koch Y., Ben-Aroya N. & Fridkin M. (2000) Molecular Pharmacology. 57, 4, p. 718-724  Abstract
  18. Yavin E., Preciado-Patt L., Rosen O., Yaron M., Suessmuth R., Levartowsky D., Jung G., Lider O. & Fridkin M. (2000) FEBS Letters. 472, 3-Feb, p. 259-262  Abstract
  19. Brosh N., Dayan M., Fridkin M. & Mozes E. (2000) Immunology Letters. 72, 1, p. 61-68  Abstract
  20. Philosof-Oppenheimer R., Hampe C., Schlessinger K., Fridkin M. & Pecht I. (2000) FEBS Journal. 267, 3, p. 703-711  Abstract
  21. Novel breast-tumor-associated MUC1-derived peptides: Characterization in Db-/- x beta 2 microglobulin (beta 2m) null mice transgenic for a chimeric HLA-A2.1/D-b-beta 2 microglobulin single chain
    Carmon L., El-Shami K., Paz A. et_al. (2000) International Journal of Cancer. 85, 3, p. 391-397  Abstract
  22. Structure activity relationship study of polymyxin B nonapeptide
    Tsubery H., Ofek I., Cohen S. & Fridkin M. (2000) Biology And Pathology Of Innate Immunity Mechanisms. 479, p. 219-222  Abstract
  23. (N-stearyl, norleucine(17)) VIP hybrid inhibits the growth of pancreatic cancer cell lines
    Zia H., Leyton J., Casibang M., Hau V., Brenneman D., Fridkin M., Gozes I. & Moody T. (2000) Life Sciences. 66, 5, p. 379-387  Abstract
  24. Offen D., Sherki Y., Melamed E., Fridkin M., Brenneman D. & Gozes I. (2000) Brain Research. 854, 2-Jan, p. 257-262  Abstract

1999

  1. Yahalom D., Chen A., Ben-Aroya N., Rahimipour S., Kaganovsky E., Okon E., Fridkin M. & Koch Y. (1999) FEBS Letters. 463, 3, p. 289-294  Abstract
  2. Pharmaceutical VIP: Prospects and problems
    Gozes I., Fridkin M., Hill J. & Brenneman D. (1999) Current Medicinal Chemistry. 6, 11, p. 1019-1034  Abstract
  3. Tirosh B., el-Shami K., Vaisman N., Carmon L., Bar-Haim E., Vadai E., Fridkin M. & Eisenbach L. (1999) Immunology Letters. 70, 1, p. 21-28  Abstract
  4. Wang H., Jiang X., Gozes I., Fridkin M., Brenneman D. & Ganea D. (1999) Regulatory Peptides. 84, 3-Jan, p. 55-67  Abstract
  5. el-Shamil K., Tirosh B., Bar-Haim E., Carmon L., Vadai E., Fridkin M. & Eisenbach L. (1999) European Journal of Immunology. 29, 10, p. 3295-3301  Abstract
  6. Goldwaser I., Li J., Gershonov E., Armoni M., Karnieli E., Fridkin M. & Shechter Y. (1999) Journal of Biological Chemistry. 274, 37, p. 26617-26624  Abstract
  7. Gershonov E., Shechter Y. & Fridkin M. (1999) Diabetes. 48, 7, p. 1437-1442  Abstract
  8. Blank M., Shoenfeld Y., Cabilly S., Heldman Y., Fridkin M. & Katchalski-Katzir E. (1999) Proceedings of the National Academy of Sciences of the United States of America. 96, 9, p. 5164-5168  Abstract
  9. Yahalom D., Koch Y., Ben-Aroya N. & Fridkin M. (1999) Life Sciences. 64, 17, p. 1543-1552  Abstract
  10. Gozes I., Perl O., Giladi E., Davidson A., Ashur-Fabian O., Rubinraut S. & Fridkin M. (1999) Proceedings of the National Academy of Sciences of the United States of America. 96, 7, p. 4143-4148  Abstract
  11. A study of extracellular matrix-cell adhesion peptidic epitopes related to human serum amyloid A (SAA)
    Preciado-Patt L., Hershkovitz R., Lider O., Feiertag S., Jung G. & Fridkin M. (1999) International Journal of Peptide Research and Therapeutics. 6, 3-Feb, p. 99-108  Abstract
  12. Konen-Waisman S., Cohen A., Fridkin M. & Cohen I. R. (1999) Journal of Infectious Diseases. 179, 2, p. 403-413  Abstract
  13. On the puzzle of the acute phase reactants C-reactive protein and serum amyloid A
    Yavin E., Preciado-Patt L., Berger H. & Fridkin M. (1999) Peptide Science - Present And Future. p. 792-796  Abstract
  14. Hill J., Lee S., Dibbern D., Fridkin M., Gozes I. & Brenneman D. (1999) Neuroscience. 93, 2, p. 783-791  Abstract
  15. Ashur-Fabian O., Perl O., Lilling G., Fridkin M. & Gozes I. (1999) Peptides. 20, 5, p. 629-633  Abstract

1998

  1. Gatt M., Urieli-Shoval S., Preciado-Patt L., Fridkin M., Calco S., Azar Y. & Matzner Y. (1998) Translational Research. 132, 5, p. 414-420  Abstract
  2. Delgado M., Munoz-Elias E., Kan Y., Gozes I., Fridkin M., Brenneman D., Gomariz R. & Ganea D. (1998) Journal of Biological Chemistry. 273, 47, p. 31427-31436  Abstract
  3. Preciado-Patt L., Cahalon L., Hershkovitz R., Lider O., Pras M. & Fridkin M. (1998) International Journal of Peptide Research and Therapeutics. 5, 6-May, p. 349-355  Abstract
  4. Eisenbach L., Mandelboim O., Bar-Haim E. et_al. (1998) International Journal of Peptide Research and Therapeutics. 5, 6-May, p. 323-328  Abstract
  5. Rahimipour S., Weiner L., Shrestha-Dawadi P., Bittner S., Koch Y. & Fridkin M. (1998) International Journal of Peptide Research and Therapeutics. 5, 6-May, p. 421-427  Abstract
  6. IL-2 induces T cell adherence to extracellular matrix: Inhibition of adherence and migration by IL-2 peptides generated by leukocyte elastase
    Ariel A., Yavin E., Hershkoviz R., Avron A., Franitza S., Hardan I., Cahalon L., Fridkin M. & Lider O. (1998) Journal of Immunology. 161, 5, p. 2465-2472  Abstract
  7. Involvement of pituitary adenylate cyclase-activating polypeptide II vasoactive intestinal peptide 2 receptor in mouse neocortical astrocytogenesis
    Zupan V., Hill J., Brenneman D., Gozes I., Fridkin M., Robberecht P., Evrard P. & Gressens P. (1998) Journal of Neurochemistry. 70, 5, p. 2165-2173  Abstract
  8. Katz-Levy Y., Dayan M., Wirguin I., Fridkin M., Sela M. & Mozes E. (1998) Journal of Neuroimmunology. 85, 1, p. 78-86  Abstract
  9. Activity-dependent neurotrophic factor: Structure-activity relationships of femtomolar-acting peptides
    Brenneman D., Hauser J., Neale E., Rubinraut S., Fridkin M., Davidson A. & Gozes I. (1998) Journal of Pharmacology and Experimental Therapeutics. 285, 2, p. 619-627  Abstract
  10. Peptides derived from human C-reactive protein inhibit the enzymatic activities of human leukocyte elastase and cathepsin G: use of overlapping peptide sequences to identify a unique inhibitor
    Yavin E. & Fridkin M. (1998) Chemical Biology and Drug Design. 51, 4, p. 282-289  Abstract
  11. Gozes I., Perl O., Zamostiano R., Rubinraut S., Fridkin M., Shochat L. & Lewin L. (1998) Vip, Pacap, And Related Peptides: Third International Symposium. 865, p. 266-273  Abstract

1997

  1. Rajnavolgyi E., Horvath A., Gogolak P., Toth G., Fazekas G., Fridkin M. & Pecht I. (1997) European Journal of Immunology. 27, 12, p. 3105-3114  Abstract
  2. Identification of shared tumor-associated antigen peptides between two spontaneous lung carcinomas
    Mandelboim O., Bar-Haim F., Vadai E., Fridkin M. & Eisenbach L. (1997) Journal of Immunology. 159, 12, p. 6030-6036  Abstract
  3. Moody T., Leyton J., Coelho T. et_al. (1997) Life Sciences. 61, 17, p. 1657-1666  Abstract
  4. Gozes I., Bachar M., Bardea A., Davidson A., Rubinraut S., Fridkin M. & Giladi E. (1997) Developmental Neurobiology. 33, 3, p. 329-342  Abstract
  5. Granoth R., Vadai E., Burstein Y., Fridkin M. & Tzehoval E. (1997) Immunopharmacology. 37, 1, p. 43-52  Abstract
  6. Extracellular matrix-anchored serum amyloid A preferentially induces mast cell adhesion
    Hershkoviz R., PreciadoPatt L., Lider O., Fridkin M., Dastych J., Metcalfe D. & Mekori Y. (1997) American Journal Of Physiology-Cell Physiology. 273, 1, p. C179-C187  Abstract
  7. Pisegna J., Leyton J., Coelho T., Hida T., Jakowlew S., Birrer M., Fridkin M., Gozes I. & Moody T. (1997) Life Sciences. 61, 6, p. 631-639  Abstract
  8. Gressens P., Marret S., Hill J., Brenneman D., Gozes I., Fridkin M. & Evrard P. (1997) Journal of Clinical Investigation. 100, 2, p. 390-397  Abstract
  9. Inhibition of human leukocyte elastase and cathepsin G by extended peptides and subunits derived from human C-reactive protein
    Yavin E., Yan L., Desiderio D., Pontet M. & Fridkin M. (1997) International Journal of Peptide Research and Therapeutics. 4, 3, p. 157-166  Abstract
  10. KatzLevy Y., PaasRozner M., Kirshner S., Dayan M., Zisman E., Fridkin M., Wirguin I., Sela M. & Mozes E. (1997) Proceedings of the National Academy of Sciences of the United States of America. 94, 7, p. 3200-3205  Abstract
  11. Gozes I., Bardea A., Bechar M. et_al. (1997) Neuropeptides In Development And Aging. 814, p. 161-166  Abstract
  12. Wu J., Henins K., Gressens P., Gozes I., Fridkin M., Brenneman D. & Hill J. (1997) Peptides. 18, 8, p. 1131-1137  Abstract

1996

  1. Binding of human serum amyloid A (hSAA) and its high-density lipoprotein(3) complex (hSAA-HDL(3)) to human neutrophils - Possible implication to the function of a protein of an unknown physiological role
    PreciadoPatt L., Pras M. & Fridkin M. (1996) International Journal of Peptide and Protein Research. 48, 6, p. 503-513  Abstract
  2. On the synthesis of naphthoquinonyl heterocyclic amino acids
    ShresthaDawadi P., Bittner S., Fridkin M. & Rahimipour S. (1996) Synthesis-Stuttgart. 12, p. 1468-&  Abstract
  3. Rahimipour S., Weiner L., Fridkin M., ShresthaDawadi P. & Bittner S. (1996) International Journal of Peptide Research and Therapeutics. 3, 5, p. 263-274  Abstract
  4. Gershonov E., Granoth R., Tzehoval E., Gaoni Y. & Fridkin M. (1996) Journal of Medicinal Chemistry. 39, 24, p. 4833-4843  Abstract
  5. Synthetic peptides derived from the sequence of human C-reactive protein inhibit the enzymatic activities of human leukocyte elastase and human leukocyte cathepsin G
    Yavin E., Yan L., Desiderio D. & Fridkin M. (1996) International Journal of Peptide and Protein Research. 48, 5, p. 465-476  Abstract
  6. Kirshner S., Zisman E., Fridkin M., Sela M. & Mozes E. (1996) Scandinavian Journal of Immunology. 44, 5, p. 512-521  Abstract
  7. Breast cancer growth is inhibited by vasoactive intestinal peptide (VIP) hybrid, a synthetic VIP receptor antagonist
    Zia H., Hida T., Jakowlew S., Birrer M., Gozes Y., Reubi J., Fridkin M., Gozes I. & Moody T. (1996) Cancer Research. 56, 15, p. 3486-3489  Abstract
  8. Zisman E., KatzLevy Y., Dayan M. et_al. (1996) Proceedings of the National Academy of Sciences of the United States of America. 93, 9, p. 4492-4497  Abstract
  9. Serum amyloid a binds specific extracellular matrix glycoproteins and induces the adhesion of resting CD4(+) T cells
    PreciadoPatt L., Hershkoviz R., Fridkin M. & Lider O. (1996) Journal of Immunology. 156, 3, p. 1189-1195  Abstract
  10. Gozes I., Bardea A., Reshef A., Zamostiano R., Zhukovsky S., Rubinraut S., Fridkin M. & Brenneman D. (1996) Proceedings of the National Academy of Sciences of the United States of America. 93, 1, p. 427-432  Abstract
  11. Development of VIP agonists and antagonists with tissue and receptor specificity: Effects on behavioral maturation, sexual function, and the biologic clock
    Gozes I., Lilling G., Davidson A. et_al. (1996) Vip, Pacap, And Related Peptides, 2Nd International Symposium. 805, p. 159-171  Abstract
  12. Synthesis of stable spirooxyphosphoranes - Potential promoters of catalytic antibodies
    Nir O., Fridkin M. & Segall Y. (1996) Phosphorus Sulfur And Silicon And The Related Elements. 109, 4-Jan, p. 241-244  Abstract

1995

  1. Gozes I., Fridkin M. & Brenneman D. (1995) Cellular and Molecular Neurobiology. 15, 6, p. 675-687  Abstract
  2. MANDELBOIM O., Vadai E., Fridkin M., KATZHILLEL A., Berke G. & Eisenbach L. (1995) Nature Medicine. 1, 11, p. 1179-1183  Abstract
  3. YAVIN E., Rosen O., PONTET M., SHEPHARD E. & Fridkin M. (1995) International Journal of Peptide Research and Therapeutics. 2, 1, p. 7-16  Abstract
  4. SELF AND FOREIGN 60-KILODALTON HEAT-SHOCK PROTEIN T-CELL EPITOPE PEPTIDES SERVE AS IMMUNOGENIC CARRIERS FOR A T-CELL-INDEPENDENT SUGAR ANTIGEN
    KONENWAISMAN S., Fridkin M. & Cohen I. R. (1995) Journal of Immunology. 154, 11, p. 5977-5985  Abstract
  5. Leibovitz D., Koch Y., Fridkin M., PITZER F., ZWICKL P., Dantes A., BAUMEISTER W. & Amsterdam A. (1995) Journal of Biological Chemistry. 270, 19, p. 11029-11032  Abstract
  6. SUPERACTIVE LIPOPHILIC PEPTIDES DISCRIMINATE MULTIPLE VASOACTIVE-INTESTINAL-PEPTIDE RECEPTORS
    GOZES I., LILLING G., GLAZER R., TICHER A., ASHKENAZI I., DAVIDSON A., Rubinraut S., Fridkin M. & BRENNEMAN D. (1995) Journal of Pharmacology and Experimental Therapeutics. 273, 1, p. 161-167  Abstract
  7. THE 2,4-DINITROPHENYL GROUP FOR PROTECTION OF HYDROXYL FUNCTION OF TYROSINE DURING SOLID-PHASE PEPTIDE-SYNTHESIS
    PHILOSOFOPPENHEIMER R., Pecht I. & Fridkin M. (1995) International Journal of Peptide and Protein Research. 45, 2, p. 116-121  Abstract

1994

  1. GRESSENS P., HILL J., PAINDAVEINE B., GOZES I., Fridkin M. & BRENNEMAN D. (1994) Journal of Clinical Investigation. 94, 5, p. 2020-2027  Abstract
  2. LANDSMANN P., Rosen O., PONTET M., PRAS M., LEVARTOWSKY D., SHEPHARD E. & Fridkin M. (1994) FEBS Journal. 223, 3, p. 805-811  Abstract
  3. PRECIADOPATT L., LEVARTOWSKY D., PRASS M., HERSHKOVIZ R., LIDER O. & Fridkin M. (1994) FEBS Journal. 223, 1, p. 35-42  Abstract
  4. Leibovitz D., Koch Y., PITZER F., Fridkin M., Dantes A., BAUMEISTER W. & Amsterdam A. (1994) FEBS Letters. 346, 3-Feb, p. 203-206  Abstract
  5. ABOUDY Y., MENDELSON E., SHALIT I., BESSALLE R. & Fridkin M. (1994) International Journal of Peptide and Protein Research. 43, 6, p. 573-582  Abstract
  6. PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP) VASOACTIVE-INTESTINAL-PEPTIDE (VIP) RECEPTOR SUBTYPES IN RAT-TISSUES - INVESTIGATION OF RECEPTOR-BINDING, A NOVEL VIP RECEPTOR ANTAGONIST AND CHEMICAL CROSS-LINKING
    SONE M., SMITH D., GHATEI M., GOZES I., BRENNEMAN D., Fridkin M. & BLOOM S. (1994) Biomedical Research-Tokyo. 15, 3, p. 145-153  Abstract
  7. MANDELBOIM O., Berke G., Fridkin M., Eisenstein M. & Eisenbach L. (1994) Nature. 369, 6475, p. 67-71  Abstract
  8. GOZES I., RESHEF A., SALAH D., Rubinraut S. & Fridkin M. (1994) Endocrinology. 134, 5, p. 2121-2125  Abstract
  9. PALMON A., BENAROYA N., TELOR S., Burstein Y., Fridkin M. & Koch Y. (1994) Proceedings of the National Academy of Sciences of the United States of America. 91, 11, p. 4994-4996  Abstract
  10. HILL J., MERVIS R., POLITI J., MCCUNE S., GOZES I., Fridkin M. & BRENNEMAN D. (1994) Models Of Neuropeptide Action. 739, p. 211-225  Abstract
  11. LILLING G., WOLLMAN Y., GOLDSTEIN M., Rubinraut S., Fridkin M., BRENNEMAN D. & GOZES I. (1994) Journal of Molecular Neuroscience. 5, 4, p. 231-239  Abstract

1993

  1. WOLLMAN Y., LILLING G., GOLDSTEIN M., Fridkin M. & GOZES I. (1993) Brain Research. 624, 2-Jan, p. 339-341  Abstract
  2. MOODY T., ZIA F., DRAOUI M., BRENNEMAN D., Fridkin M., DAVIDSON A. & GOZES I. (1993) Proceedings of the National Academy of Sciences of the United States of America. 90, 10, p. 4345-4349  Abstract
  3. BESSALLE R., GOREA A., SHALIT I., METZGER J., DASS C., DESIDERIO D. & Fridkin M. (1993) Journal of Medicinal Chemistry. 36, 9, p. 1203-1209  Abstract
  4. GRESSENS P., HILL J., GOZES I., Fridkin M. & BRENNEMAN D. (1993) Nature. 362, 6416, p. 155-158  Abstract
  5. GECHTMAN Z., SHARMA R., Kreizman T., Fridkin M. & SHALTIEL S. (1993) FEBS Letters. 315, 3, p. 293-297  Abstract
  6. NEUROHORMONES IN MILK
    Koch Y. & Fridkin M. (1993) Progress In Endocrinology. 3, p. 685-687  Abstract
  7. SYNTHESIS AND BIOLOGICAL-ACTIVITY OF [L-HYDROXYPROLINE]3-TUFTSIN ANALOG AND ITS ALPHA-O-D-GLUCOSYLATED OR BETA-O-D-GLUCOSYLATED DERIVATIVES
    BIONDI L., FILIRA F., ROCCHI R., Tzehoval E. & Fridkin M. (1993) International Journal of Peptide and Protein Research. 41, 1, p. 43-51  Abstract

1992

  1. GOZES I. & Fridkin M. (1992) Journal of Clinical Investigation. 90, 3, p. 810-814  Abstract
  2. C-REACTIVE PROTEIN (CRP) PEPTIDES INACTIVATE ENOLASE IN HUMAN NEUTROPHILS LEADING TO DEPLETION OF INTRACELLULAR ATP AND INHIBITION OF SUPEROXIDE GENERATION
    SHEPHARD E., ANDERSON R., Rosen O. & Fridkin M. (1992) Immunology. 76, 1, p. 79-85  Abstract
  3. YING S., SHEPHARD E., DEBEER F., SIEGEL J., HARRIS D., GEWURZ B., Fridkin M. & GEWURZ H. (1992) Molecular Immunology. 29, 5, p. 677-687  Abstract
  4. CHARACTERIZATION OF NEUTROPHIL-MEDIATED DEGRADATION OF HUMAN C-REACTIVE PROTEIN AND IDENTIFICATION OF THE PROTEASE
    SHEPHARD E., KELLY S., ANDERSON R. & Fridkin M. (1992) Clinical and Experimental Immunology. 87, 3, p. 509-513  Abstract
  5. AUGMENTATION OF THE ANTIBACTERIAL ACTIVITY OF MAGAININ BY POSITIVE-CHARGE CHAIN EXTENSION
    BESSALLE R., HAAS H., GORIA A., SHALIT I. & Fridkin M. (1992) Antimicrobial Agents and Chemotherapy. 36, 2, p. 313-317  Abstract
  6. GLOWA J., PANLILIO L., BRENNEMAN D., GOZES I., Fridkin M. & HILL J. (1992) Brain Research. 570, 2-Jan, p. 49-53  Abstract
  7. VIP ANALOGS INHIBIT SMALL-CELL LUNG-CANCER GROWTH
    MOODY T., ZIA F., GOLDSTEIN A. et_al. (1992) Biomedical Research-Tokyo. 13, p. 131-135  Abstract

1991

  1. GOZES I., MCCUNE S., JACOBSON L., WARREN D., MOODY T., Fridkin M. & BRENNEMAN D. (1991) Journal of Pharmacology and Experimental Therapeutics. 257, 3, p. 959-966  Abstract
  2. GLYCO-TUFTSIN DERIVATIVES MODULATE INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR PRODUCTION
    ROCCHI R., BIONDI L., FILIRA F., Tzehoval E., Dagan S. & Fridkin M. (1991) International Journal of Peptide and Protein Research. 37, 3, p. 161-166  Abstract
  3. GOZES Y., BRENNEMAN D., Fridkin M., ASOFSKY R. & GOZES I. (1991) Brain Research. 540, 2-Jan, p. 319-321  Abstract
  4. HILL J., GOZES I., HILL J., Fridkin M. & BRENNEMAN D. (1991) Peptides. 12, 1, p. 187-192  Abstract
  5. GENERATION AND USE OF ANTIBODIES TO PHOSPHOTHREONINE
    HEFFETZ D., Fridkin M. & Zick Y. (1991) Methods in Enzymology. 201, p. 44-53  Abstract

1990

  1. BESSALLE R., Kapitkovsky A., GOREA A., SHALIT I. & Fridkin M. (1990) FEBS Letters. 274, 2-Jan, p. 151-155  Abstract
  2. PEPTIDES GENERATED FROM C-REACTIVE PROTEIN BY A NEUTROPHIL MEMBRANE PROTEASE - AMINO-ACID-SEQUENCE AND EFFECTS OF PEPTIDES ON NEUTROPHIL OXIDATIVE-METABOLISM AND CHEMOTAXIS
    SHEPHARD E., ANDERSON R., Rosen O., MYER M., Fridkin M., STRACHAN A. & DEBEER F. (1990) Journal of Immunology. 145, 5, p. 1469-1476  Abstract
  3. KORNBERG A., CATANE R., PELLER S., Kaufman S. & Fridkin M. (1990) Blood. 76, 4, p. 814-819  Abstract
  4. Goren A., Zohar Y., Fridkin M., ELHANATI E. & Koch Y. (1990) General and Comparative Endocrinology. 79, 2, p. 291-305  Abstract
  5. THIOLYSIS OF THE 3-NITRO-2-PYRIDINESULFENYL (NPYS) PROTECTING GROUP - AN APPROACH TOWARDS A GENERAL DEPROTECTION SCHEME IN PEPTIDE-SYNTHESIS
    Rosen O., Rubinraut S. & Fridkin M. (1990) International Journal of Peptide and Protein Research. 35, 6, p. 545-549  Abstract
  6. SURKIS R., Rubinraut S., Dagan S., Tzehoval E., Fridkin M., BENYOSEPH R. & CATANE R. (1990) International Journal of Biochemistry and Cell Biology. 22, 2, p. 193-195  Abstract

1989

  1. GOZES I., MELTZER E., RUBINROUT S., BRENNEMAN D. & Fridkin M. (1989) Endocrinology. 125, 6, p. 2945-2949  Abstract
  2. KAIN Z., ALKAN M., CHAIMOVITZ C., SEGAL S., Fridkin M. & Levy R. (1989) Immunology Letters. 21, 3, p. 257-261  Abstract
  3. Tuftsin stimulates IL-1 production by human mononuclear cells, human spleen cells and mouse spleen cells in vitro
    SPIRER Z., ZAKUTH V., Tzehoval E., Dagan S., Fridkin M., GOLANDER A. & MELAMED I. (1989) Journal Of Clinical & Laboratory Immunology. 28, 1, p. 27-31  Abstract
  4. GOZES I., WERNER H., FAWZI M., ABDELATTY A., Shani Y., Fridkin M. & Koch Y. (1989) Journal of Molecular Neuroscience. 1, 1, p. 55-61  Abstract
  5. Fridkin M. & NAJJAR V. (1989) Critical Reviews in Biochemistry and Molecular Biology. 24, 1, p. 1-40  Abstract

1988

  1. Antigen-Tuftsin Conjugate Signals Interleukin-1 Synthesis and Secretion
    Dagan S., Tzehoval E., TARTAKOVSKY B., Fridkin M. & Feldman M. (1988) Journal of Immunotherapy. 7, 6, p. 546-558  Abstract
  2. BUCHTA R., GENNARO R., PONTET M., Fridkin M. & ROMEO D. (1988) FEBS Letters. 237, 2-Jan, p. 173-177  Abstract
  3. WERNER H., KATZ P., Fridkin M., Koch Y. & LEVINE S. (1988) European Journal of Pediatrics. 147, 3, p. 252-256  Abstract

1987

  1. Dagan S., Tzehoval E., Fridkin M. & Feldman M. (1987) Journal of Immunotherapy. 6, 6, p. 625-636  Abstract
  2. Fuchs S., NEUMANN D., SAFRAN A., SOUROUJON M., Barchan D., Fridkin M., GERSHONI J., MANTEGAZZA R. & PIZZIGHELLA S. (1987) Annals of the New York Academy of Sciences. 505, p. 256-271  Abstract
  3. BUCHTA R., Fridkin M., PONTET M., CONTESSI E., SCAGGIANTE B. & ROMEO D. (1987) FEBS Journal. 163, 1, p. 141-146  Abstract
  4. SYNTHESIS AND BIOLOGICAL-ACTIVITY OF TUFTSIN AND RIGIN DERIVATIVES CONTAINING MONOSACCHARIDES OR MONOSACCHARIDE DERIVATIVES
    ROCCHI R., BIONDI L., CAVAGGION F., FILIRA F., GOBBO M., Dagan S. & Fridkin M. (1987) International Journal of Peptide and Protein Research. 29, 2, p. 262-275  Abstract
  5. SYNTHESIS OF MODIFIED TUFTSINS CONTAINING MONOSACCHARIDES OR MONOSACCHARIDE DERIVATIVES
    ROCCHI R., BIONDI L., FILIRA F., GOBBO M., Dagan S. & Fridkin M. (1987) International Journal of Peptide and Protein Research. 29, 2, p. 250-261  Abstract
  6. BUCHTA R., PONTET M. & Fridkin M. (1987) FEBS Letters. 211, 2, p. 165-168  Abstract

1986

  1. NEUMANN D., Barchan D., Fridkin M. & Fuchs S. (1986) Proceedings of the National Academy of Sciences of the United States of America. 83, 23, p. 9250-9253  Abstract
  2. Dagan S., GOTTLIEB P., Tzehoval E., Fridkin M., YASUMURA K., OKAMOTO K. & YAJIMA H. (1986) Journal of Medicinal Chemistry. 29, 10, p. 1961-1968  Abstract
  3. PEPTIDES RELATED TO THE CALCIUM-BINDING DOMAIN-II AND DOMAIN-III OF CALMODULIN - SYNTHESIS AND CALMODULIN-LIKE FEATURES
    BUCHTA R., BONDI E. & Fridkin M. (1986) International Journal of Peptide and Protein Research. 28, 3, p. 289-297  Abstract
  4. LOCALIZATION OF GROWTH HORMONE-RELEASING HORMONE IN THE HUMAN HYPOTHALAMUS AND PITUITARY-STALK
    WERNER H., Okon E., Fridkin M. & Koch Y. (1986) Journal Of Clinical Endocrinology & Metabolism. 63, 1, p. 47-50  Abstract
  5. WERNER H., AMARANT T., Fridkin M. & Koch Y. (1986) Biochemical and Biophysical Research Communications. 135, 3, p. 1084-1089  Abstract
  6. SOUROUJON M., Neumann D., PIZZIGHELLA S., Fridkin M. & Fuch S. (1986) EMBO Journal. 5, 3, p. 543-546  Abstract
  7. INITIAL CLINICAL-STUDIES WITH TUFTSIN
    CATANE R., SULKES A., UZIELY B., GEZ E., ISACSON R., TREVES A. & Fridkin M. (1986) International Journal of Immunotherapy. 2, 1, p. 81-85  Abstract
  8. GOZES I., BODNER M., Shani Y. & Fridkin M. (1986) Peptides. 7, p. 1-6  Abstract

1985

  1. BUCHTA R. & Fridkin M. (1985) Biochemical and Biophysical Research Communications. 130, 1, p. 350-357  Abstract
  2. CROSS RESISTANCE TO ESTERS OF METHOTREXATE IN A DOXORUBICIN-RESISTANT SUBLINE OF P388 MURINE LEUKEMIA
    RAMU A., Fridkin M. & STEINHERZ R. (1985) Cancer Chemotherapy and Pharmacology. 15, 1, p. 31-34  Abstract
  3. NEUMANN D., GERSHONI J., Fridkin M. & Fuchs S. (1985) Proceedings of the National Academy of Sciences of the United States of America. 82, 10, p. 3490-3493  Abstract
  4. WERNER H., AMARANT T., MILLAR R., Fridkin M. & Koch Y. (1985) FEBS Journal. 148, 2, p. 353-357  Abstract
  5. WERNER H., Fridkin M., AVIV D. & Koch Y. (1985) Peptides. 6, 5, p. 797-802  Abstract
  6. WERNER H., Koch Y., Fridkin M., FAHRENKRUG J. & GOZES I. (1985) Biochemical and Biophysical Research Communications. 133, 1, p. 228-232  Abstract
  7. KRIS R., LAX I., GULLICK W., WATERFIELD M., ULLRICH A., Fridkin M. & SCHLESSINGER J. (1985) Cell. 40, 3, p. 619-625  Abstract
  8. BODNER M., Fridkin M. & GOZES I. (1985) Proceedings of the National Academy of Sciences of the United States of America. 82, 11, p. 3548-3551  Abstract
  9. KRIS R., LAX I., SASSON I. et_al. (1985) Biochimie. 67, 1-Oct, p. 1095-1101  Abstract
  10. NON-IMMUNE INTERACTION OF ERYTHROPHILIC IGG FRACTIONS WITH HUMAN RED BLOOD-CELLS
    Dagan S., BERETZ A., Fridkin M., Burstein Y. & SPIRER Z. (1985) Molecular and Cellular Biochemistry. 66, 1, p. 5-11  Abstract

1984

  1. GOZES I., BODNER M., SHWARTZ H., Shani Y. & Fridkin M. (1984) Peptides. 5, 2, p. 161-166  Abstract
  2. NEUMANN D., Fridkin M. & Fuchs S. (1984) Biochemical and Biophysical Research Communications. 121, 2, p. 673-679  Abstract
  3. GOTTLIEB P., Hazum E., Tzehoval E., SEGAL S. & Fridkin M. (1984) Biochemical and Biophysical Research Communications. 119, 1, p. 203-211  Abstract
  4. GOZES I., BODNER M., Shani Y. & Fridkin M. (1984) Journal of Cellular Biochemistry. 26, 3, p. 147-156  Abstract

1983

  1. KNYSZYNSKI A., GOTTLIEB P. & Fridkin M. (1983) Journal of the National Cancer Institute. 71, 1, p. 87-90  Abstract
  2. GOTTLIEB P., STABINSKY Y., HILLER Y. et_al. (1983) Annals of the New York Academy of Sciences. 419, DEC, p. 93-106  Abstract
  3. GOTTLIEB P., Tzehoval E., SEGAL S. & Fridkin M. (1983) Biochemical and Biophysical Research Communications. 115, 1, p. 193-200  Abstract
  4. GOTTLIEB P., STABINSKY Y., ZAKUTH V., SPIRER Z. & Fridkin M. (1983) Annals of the New York Academy of Sciences. 419, DEC, p. 12-22  Abstract
  5. CATANE R., SCHLANGER S., WEISS L., PENCHAS S., FUKS Z., TREVES A., GOTTLIEB P. & Fridkin M. (1983) Annals of the New York Academy of Sciences. 419, DEC, p. 251-260  Abstract
  6. GOTTLIEB P., Tzehoval E., SEGAL S. & Fridkin M. (1983) Annals of the New York Academy of Sciences. 419, DEC, p. 107-113  Abstract
  7. SPIRER Z., ZAKUTH V., ORDA R., WIZNITZER T., MONDORF W., STEFANESCU T. & Fridkin M. (1983) Annals of the New York Academy of Sciences. 419, DEC, p. 220-226  Abstract
  8. MILTON R., KING J., BADMINTON M., TOBLER C., LINDSEY G., Fridkin M. & MILLAR R. (1983) Biochemical and Biophysical Research Communications. 111, 3, p. 1082-1088  Abstract

1982

  1. Stern M., Fridkin M. & WARSHAWSKY A. (1982) Journal Of Polymer Science Part A-Polymer Chemistry. 20, 6, p. 1469-1487  Abstract
  2. GOTTLIEB P., BERETZ A. & Fridkin M. (1982) FEBS Journal. 125, 3, p. 631-638  Abstract
  3. MECHANISMS CONTROLLING DIFFERENTIATION AND FUNCTION OF ANTIGEN-PRESENTING MACROPHAGES
    Tzehoval E., RON Y., DEBAETSELIER P., Fridkin M. & SEGAL S. (1982) Advances in Experimental Medicine and Biology. 155, p. 543-548  Abstract
  4. LUTEINIZING-HORMONE-RELEASING HORMONE AND THYROTROPIN-RELEASING-HORMONE IN HUMAN AND BOVINE-MILK
    AMARANT T., Fridkin M. & Koch Y. (1982) FEBS Journal. 127, 3, p. 647-650  Abstract

1981

  1. Tryptophan residues of cholera toxin and its A and B protomers .Intrinsic fluorescence and solute quenching upon interacting with the ganglioside GM1, oligo-GM1, or dansylated oligo-GM1
    DE WOLF M., Fridkin M. & KOHN L. (1981) Journal of Biological Chemistry. 256, 11, p. 5489-5496  Abstract
  2. POLYMERIC 2-MERCAPTOPYRIDINE AND 2-MERCAPTO-NITROBENZENE DERIVATIVES - NEW REAGENTS FOR PEPTIDE-SYNTHESIS
    Stern M., WARSHAWKSY A. & Fridkin M. (1981) International Journal of Peptide and Protein Research. 17, 5, p. 531-538  Abstract
  3. DEGRADATION OF GONADOTROPIN-RELEASING HORMONE BY ANTERIOR-PITUITARY ENZYMES
    Hazum E., Fridkin M., BARAM T. & Koch Y. (1981) FEBS Letters. 127, 2, p. 273-276  Abstract
  4. ENHANCEMENT OF PHAGOCYTOSIS BY SUBSTANCE-P AND ITS N-TERMINAL TETRAPEPTIDE
    BARSHAVIT Z., Goldman R., STABINSKY Y., GOTTLIEB P., Fridkin M., TEICHBERG V. & BLUMBERG S. (1981) Israel Medical Association Journal. 17, 5, p. 392-392  Abstract
  5. TUFTSIN, THR-LYS-PRO-ARG - ANATOMY OF AN IMMUNOLOGICALLY ACTIVE PEPTIDE
    Fridkin M. & GOTTLIEB P. (1981) Molecular and Cellular Biochemistry. 41, DEC, p. 73-97  Abstract
  6. STRUCTURE-FUNCTION STUDIES OF CHOLERA-TOXIN AND ITS A-PROTOMERS AND B-PROTOMERS - MODIFICATION OF TRYPTOPHAN RESIDUES
    DEWOLF M., Fridkin M., Epstein M. & KOHN L. (1981) Journal of Biological Chemistry. 256, 11, p. 5481-5488  Abstract
  7. ELKABES S., Fridkin M. & Koch Y. (1981) Biochemical and Biophysical Research Communications. 103, 1, p. 240-248  Abstract

1980

  1. THE PHAGOCYTOSIS STIMULATING PEPTIDE TUFTSIN - FURTHER LOOK INTO STRUCTURE-FUNCTION-RELATIONSHIPS
    STABINSKY Y., GOTTLIEB P. & Fridkin M. (1980) Molecular and Cellular Biochemistry. 30, 3, p. 165-170  Abstract
  2. BARSHAVIT Z., Goldman R., STABINSKY Y., GOTTLIEB P., Fridkin M., TEICHBERG V. & BLUMBERG S. (1980) Biochemical and Biophysical Research Communications. 94, 4, p. 1445-1451  Abstract
  3. DECREASED SERUM TUFTSIN CONCENTRATIONS IN SICKLE-CELL DISEASE
    SPIRER Z., WEISMAN Y., ZAKUTH V., Fridkin M. & BOGAIR N. (1980) Archives of Disease in Childhood. 55, 7, p. 566-567  Abstract
  4. ON THE MECHANISM OF ACTION OF THE PHAGOCYTOSIS-STIMULATING PEPTIDE TUFTSIN
    STABINSKY Y., BARSHAVIT Z., Fridkin M. & Goldman R. (1980) Molecular and Cellular Biochemistry. 30, 2, p. 71-77  Abstract

1979

  1. BARSHAVIT Z., Goldman R., STABINSKY Y. & Fridkin M. (1979) Journal of Cellular Physiology. 100, 1, p. 55-62  Abstract
  2. Tzehoval E., SEGAL S., STABINSKY Y., Fridkin M. & SPIRER Z. (1979) Seminars in Immunopathology. 2, 2, p. 205-214  Abstract
  3. FACILE THIOLYTIC REMOVAL OF THE ORTHO-NITROPHENYLSULFENYL AMINO-PROTECTING GROUP
    Stern M., WARSHAWSKY A. & Fridkin M. (1979) International Journal of Peptide and Protein Research. 13, 3, p. 315-319  Abstract
  4. SPIRER Z., ZAKUTH V., DIAMANT S., STABINSKY Y. & Fridkin M. (1979) Experientia. 35, 6, p. 830-831  Abstract

1978

  1. SYNTHESIS AND BIOLOGICAL-ACTIVITY OF TUFTSIN AND OF [O=C-THR1]-TUFTSIN - NOVEL SYNTHETIC ROUTE TO PEPTIDES CONTAINING N-TERMINAL L-O=C-THR AND L-O=C-SER RESIDUES
    STABINSKY Y., Fridkin M., ZAKUTH V. & SPIRER Z. (1978) International Journal of Peptide and Protein Research. 12, 3, p. 130-138  Abstract
  2. STABINSKY Y., GOTTLIEB P., ZAKUTH V., SPIRER Z. & Fridkin M. (1978) Biochemical and Biophysical Research Communications. 83, 2, p. 599-606  Abstract
  3. GOREN H., FLETCHER T., Fridkin M. & KATCHALSKIKATZIR E. (1978) Biopolymers. 17, 7, p. 1679-1692  Abstract
  4. Tzehoval E., SEGAL S., STABINSKY Y., Fridkin M. & SPIRER Z. (1978) Proceedings of the National Academy of Sciences of the United States of America. 75, 7, p. 3400-3404  Abstract
  5. THIOLYSIS OF NIM-2, 4-DINITROPHENYL-HISTIDINE PEPTIDES WITH 2-MERCAPTOETHANOL - EXPLANATION FOR PH OPTIMUM
    GOREN H. & Fridkin M. (1978) International Journal of Peptide and Protein Research. 11, 1, p. 1-8  Abstract
  6. Hazum E., Fridkin M., MEIDAN R. & Koch Y. (1978) International Journal of Biochemistry and Cell Biology. 9, 6, p. 385-388  Abstract

1977

  1. Koch Y., BARAM T., Hazum E. & Fridkin M. (1977) Biochemical and Biophysical Research Communications. 74, 2, p. 488-491  Abstract
  2. Fridkin M., Hazum E., TAUBERFINKELSTEIN M. & SHALTIEL S. (1977) Archives of Biochemistry and Biophysics. 178, 2, p. 517-526  Abstract
  3. Hazum E., Fridkin M., MEIDAN R. & Koch Y. (1977) FEBS Letters. 76, 2, p. 187-190  Abstract
  4. GOREN H., KATCHALSKIKATZIR E. & Fridkin M. (1977) Biopolymers. 16, 10, p. 2265-2279  Abstract
  5. SPIRER Z., ZAKUTH V., BOGAIR N. & Fridkin M. (1977) European Journal of Immunology. 7, 2, p. 69-74  Abstract
  6. Fridkin M., STABINSKY Y., ZAKUTH V. & SPIRER Z. (1977) Biochimica Et Biophysica Acta. 496, 1, p. 203-211  Abstract
  7. Hazum E., Fridkin M., MEIDAN R. & Koch Y. (1977) FEBS Journal. 79, 1, p. 269-273  Abstract
  8. DECREASED TUFTSIN CONCENTRATIONS IN PATIENTS WHO HAVE UNDERGONE SPLENECTOMY
    SPIRER Z., ZAKUTH V., DIAMANT S., MONDORF W., STEFANESCU T., STABINSKY Y. & Fridkin M. (1977) British Medical Journal. 2, 6102, p. 1574-1576  Abstract
  9. BARAM T., Koch Y., Hazum E. & Fridkin M. (1977) Science. 198, 4314, p. 300-302  Abstract
  10. PHOTOLABILE PROTECTING GROUP FOR PHENOLIC HYDROXYL FUNCTION OF TYROSINE
    AMIT B., Hazum E., Fridkin M. & Patchornik A. (1977) International Journal of Peptide and Protein Research. 9, 2, p. 91-96  Abstract

1976

  1. Koch Y., BARAM T. & Fridkin M. (1976) FEBS Letters. 63, 2, p. 295-298  Abstract
  2. SHINITZKY M. & Fridkin M. (1976) Biochimica Et Biophysica Acta. 434, 1, p. 137-143  Abstract
  3. SHINITZKY M., Hazum E. & Fridkin M. (1976) Biochimica Et Biophysica Acta. 453, 2, p. 553-557  Abstract

1975

  1. KALIR R., WARSHAWSKY A., Fridkin M. & Patchornik A. (1975) FEBS Journal. 59, 1, p. 55-61  Abstract
  2. SPIRER Z., ZAKUTH V., GOLANDER A., BOGAIR N. & Fridkin M. (1975) Journal of Clinical Investigation. 55, 1, p. 198-200  Abstract

1974

  1. Koch Y., BARAM T. & Fridkin M. (1974) Biochemical and Biophysical Research Communications. 61, 1, p. 95-103  Abstract
  2. GOREN H. & Fridkin M. (1974) FEBS Journal. 41, 2, p. 263-272  Abstract
  3. Fridkin M. (1974) Annual Review of Biochemistry. 43, p. 419-443  Abstract

1973

  1. Koch Y., ZOR U., Fridkin M. & LINDNER H. (1973) Biochemical and Biophysical Research Communications. 55, 3, p. 623-629  Abstract
  2. Koch Y., Wilchek M., Fridkin M., ZOR U. & LINDNER H. (1973) Biochemical and Biophysical Research Communications. 55, 3, p. 616-622  Abstract